title: Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy.
abstract: BACKGROUND
  The most striking abnormality in the renin angiotensin system in diabetic nephropathy (DN) is increased plasma prorenin. Renin is thought to be low or normal in DN. In spite of altered (pro)renin regulation the renin gene has not been studied for contribution to the development of DN.
  
  
  METHODS
  We studied plasma renin, prorenin, and four polymorphic markers of the renin gene in 199 patients with IDDM and DN, and in 192 normoalbuminuric IDDM controls matched for age, sex, and duration of diabetes. Plasma renin and total renin were measured by immunoradiometric assays. Genotyping was PCR-based.
  
  
  RESULTS
  Plasma renin was increased in patients with nephropathy (median (range), 26.3 (5.2-243.3) vs 18.3 (4.2-373.5) microU/ml in the normoalbuminuric group, P<0.0001). Prorenin levels were elevated out of proportion to renin levels in nephropathic patients (789 (88-5481) vs 302 (36-2226) microU/ml, P<0.0001). Proliferative retinopathy had an additive effect on plasma prorenin, but not on renin. DN was associated with a BglI RFLP in the first intron of the renin gene (bb-genotype: n=106 vs 82 in DN and normoalbuminuric patients respectively, P=0.037), but not with three other polymorphisms in the renin gene. A trend for association of higher prorenin levels with the DN-associated allele of this renin polymorphism was observed in a subgroup of patients with DN (bb vs Bb+BB, P=0.07).
  
  
  CONCLUSIONS
  The results indicate that in DN there is an increase in both renin and prorenin levels. A renin gene polymorphism may contribute weakly to DN. Although speculative, one of the renin gene alleles could lead to increased renin gene expression, leading to higher renin and prorenin levels. These may play a role in the pathogenesis of DN.
authors.affiliation: Department of Internal Medicine I, University Hospital Dijkzigt, Rotterdam, The Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: Deinum
authors.forename: L
authors.initials: L
authors.lastname: Tarnow
authors.forename: J M
authors.initials: JM
authors.lastname: van Gool
authors.forename: R A
authors.initials: RA
authors.lastname: de Bruin
authors.forename: F H
authors.initials: FH
authors.lastname: Derkx
authors.forename: M A
authors.initials: MA
authors.lastname: Schalekamp
authors.forename: H H
authors.initials: HH
authors.lastname: Parving
mesh_terms: D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000235:genetics; D003928:Diabetic Nephropathies / Q000097:blood* / Q000235:genetics*; D003930:Diabetic Retinopathy / Q000097:blood; D004792:Enzyme Precursors / Q000097:blood*; D005260:Female; D014644:Genetic Variation / Q000502:physiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic / Q000502:physiology; D012083:Renin / Q000097:blood* / Q000235:genetics*
chemical_list: D004792:Enzyme Precursors; D012083:Renin